SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-21-016438
Filing Date
2021-05-07
Accepted
2021-05-07 16:13:01
Documents
1
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP II, L.P.VENBIO GLOBAL STRATEGIC GP II, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10024239_sc13da.htm SC 13D/A 197217
  Complete submission text file 0001140361-21-016438.txt   198922
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91047 | Film No.: 21902794
SIC: 2834 Pharmaceutical Preparations